J&J Stent Patents Found Invalid In Boston Sci Suit

“Boston Scientific Corp. has prevailed in a consolidated suit against Johnson & Johnson Inc., now that a federal judge has found invalid four J&J patents for a drug-eluting stent.”

“The summary judgment ruling Wednesday by Judge Sue L. Robinson of the U.S. District Court for the District of Delaware halted a trial that was to begin in February.”

“In a memorandum opinion, Judge Robinson held that the disputed claims of the four patents—which J&J alleged were infringed by the Promus stent system produced by BSC—lacked adequate written description.”

“BSC welcomed the court’s finding Thursday.””

Howrey LLP represents Boston Scientific Corporation.